Company:  ATRICURE, INC. (ATRC)
Form Type:  4
Filing Date:  2/16/2012 
CIK:  0001323885 
Address:  6217 CENTRE PARK DRIVE 
City, State, Zip:  WEST CHESTER, Ohio 45069 
Telephone:  513-755-4107 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$24.46  
Change: 
-1.04 (-4.08%)  
Trade Time: 
Aug 31  
Market Cap: 
$698.02M
Trade ATRC now with 

Description of Business
We are a medical device company providing innovative atrial fibrillation (Afib) solutions designed to produce superior outcomes that reduce the economic and social burden of atrial fibrillation. We have two primary product lines for the ablation of cardiac tissue. Our Isolator Synergy® Ablation System is the first and only surgical device approved by the United States Food and Drug Administration (FDA) for the treatment of Afib. Our cryoICE(TM) cryosurgery product line offers a variety of both single use and reusable cryoablation devices. Our AtriClip® Left Atrial Appendage Exclusion System is the most widely sold device worldwide specifically designed to occlude the heart's left atrial appendage (LAA). We believe cardiothoracic surgeons are adopting our ablation and LAA management (LAAM) devices to cure Afib and reduce Afib-related complications such as stroke.
Register and access this filing in:     
  FORM 4
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    EXPLANATIONS AND REMARKS
    REPORTING OWNERS
    SIGNATURES